The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 1, 2006, Pages 34-40

  Arici, Mustafa Kemal ^a   Erdogan, Haydar ^a   Toker, Ilker ^a   Vural, Ayse ^a   Topalkara, Aysen ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; ARTIFICIAL TEAR; BETAXOLOL; BIMATOPROST; BRIMONIDINE; BUPIVACAINE; CYCLOPENTOLATE; DEXAMETHASONE; DORZOLAMIDE; FENILEFRIN; JETOKAIN; LATANOPROST; LIDOCAINE; PHENYLEPHRINE; PLACEBO; SIKLOPLEJIN; TEARS NATURALE; TIMOLOL; TOBRAMYCIN; TRAVOPROST; TROPAMID FORTE; TROPICAMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRACRANIAL HYPERTENSION; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PHACOEMULSIFICATION; POSTERIOR EYE CHAMBER; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; TONOMETRY;

ADMINISTRATION, TOPICAL; AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LENS IMPLANTATION, INTRAOCULAR; LIPIDS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC;

EID: 33644837911     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.34     Document Type: Article

References (33)

1. Lai, J.S.M., Chua, J.K.H., Leung, A.T.S., et al. Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. J. Cataract Refract. Surg. 26:386-391, 2000.
2. Gross, J.G., Meyer, D.R., Robin, A.L., et al. Increased intraocular pressure in the immediate postoperative period after extracapcular cataract extraction. Am. J. Ophthalmol. 105:466-469, 1998.
3. Kooner, K.S., Cooksey, J.C., Perry, P., et al. Intraocular pressure following ECCE, phacoemulsification, and PC-IOL implantation. Ophthal. Surg. 19:643-646, 1998.
4. Passo, M.S., Ernest, J.T., and Goldstick, T.K. Hyaluronate increases intraocular pressure when used in cataract extraction. Br. J. Ophthalmol. 69:572-575, 1985.
5. Rainer, G., Menapace, R., Schmetterer, K., et al. Effect of dorzolamide and latanoprost on intraocular pressure after small incision cataract surgery. J. Cataract Refract. Surg. 25:1624-1629, 1999.
6. Scherer, W.J., Mielke, D.L., Tidwell, P.E., et al. Effect of latanoprost on intraocular pressure following cataract extraction. J. Cataract Refract. Surg. 24:964-967, 1998.
7. Lai, J.S.M., Loo, A., Tham, C.C.Y., et al. Preoperative latanoprost to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. J. Cataract Refract. Surg. 27:1792-1795, 2001.
8. Katsimpris, J.M., Siganos, D., Konstas, A.G.P., et al. Efficacy of brimonidine 0.2% in contolling acute post-operative intraocular pressure elevation after phacoemulsification. J. Cataract Refract. Surg. 29:2288-2294, 2003.
9. Şimşek, S., Demirok, A., Yasar, T., et al. Effect of 0.5% and 0.25% apraclonidine on postoperative intraocular hypertension after cataract extraction. Eur. J. Ophthalmol. 8:67-70, 1998.
10. Sterk, C.C., Renzenbrink-Bubberman, A.C., and Van Best, J.A. Effect of 1% apraclonidine on intraocular pressure after cataract surgery. Ophthal. Surg. Laser 29:472-475, 1998.
11. Alexander, C.L., Miller, S.J., and Abel, S.R. Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann. Pharmacother. 36:504-511, 2002.
12. Parrish, R.K., Palmberg, P., and Sheu, W.P., for the XLT Study Group. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator, multicenter study. Am. J. Ophthalmol. 135: 688-703, 2003.
13. Toris, C.B., Camras, C.B., and Yablonski, M.E. Effects of PhXA41, a new prostaglandin F21, analog, on aqueous humor dynamics in human eyes. Ophthalmology 100:1297-1304, 1993.
14. Arici, K., Topalkara, A., and Güler, C. Tek doz topikal latanoprost'un goziçi basincina etkisi. [Effects on intraocular pressure of a single dose of latanoprost.] MN Oftalmoloji 5:363-264, 1997.
15. Arici, M.K., Güler, C., Topalkara, A., et al. Latanoprost'un oküler hipertansif ve normotansif hastalarda gözici basmcina etkisi. [Effects on intraocular pressure of latanoprost in ocular normotensive and hypertensive patients.] TOD Gazetesi 28:97-100, 1998.
16. Lindsey, J.D., Kashiwagi, K., and Weinreb, R.N. Prostaglandin action on ciliary smooth muscle extra-cellular matrix metabilism: Implications for uveascleral outflow. Surv. Ophthalmol. 41(suppl 2):S53-S59, 1997.
17. 2α analoque, and timolol in patients with elevated intraocular pressure. Br. J. Ophthalmol. 78:899-902, 1994.
18. Arici, M.K., Güler, C., Topalkara, A., et al. Latanoprost ve Betaxolol kombinasyonunun göziçi basinci üzerine kïsa süre etkisinin incelenmesi. [Evaluation of the short term effect of combined therapy with latanoprost and Betaxolol on intraocular pressure.] MN Oftalmoloji 6:123-126, 1999.
19. Arici, M.K., Güler, C., and Topalkara. A. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure. Int. Ophthalmol. 22:37-42,1998.
20. Handa, J., Henry, J.C., Krupin, T., et al. Extracpasular cataract extraction with posterior chamber lens implantation in patients with glaucoma. Arch. Ophthalmol. 105:765-769, 1987.
21. Vu, M.T., and Shields, M.B. The early postoperative pressure course in glaucoma patients following cataract surgery. Ophthal. Surg. 19:467-470, 1988.
22. Hayreh, S.S. Anterior ischemic optic neuropathy. IV: Occurence after cataract extraction. Arch. Ophthalmol. 98:1410-1416, 1980.
23. Woodward, D.F. Krauss, A.H.P., Chen, J., et al. The pharmacology of bimatoprost (Lumigan). Surv. Ophthalmol. 45(Suppl 4):337-345, 2001.
24. Eisenberg, D.L., Toris, C.B., and Camras, C.B. Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs. Surv. Ophthalmol. 47(Suppl):S105-S115, 2002.
25. Sharif, N.A., Williams, G.W., and Kelly, C.R. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur. J. Pharmacol. 432:211-213, 2001.
26. Maxey, K.M., Johnson, J.L., and LaBrecque, J. The hydrolysis of bimatoprost in corneal tissue generated a potent prostanoid FP receptor agonist. Surv. Ophthalmol. 47(Suppl):S34-S40, 2002.
27. 2α, analogue after topical application in normal and ocular hypertensive human eyes. Arch. Ophthalmol. 111:1352-1358, 1993.
28. Brubaker, R.F., Schoff, E.O., Nau, C.B., et al. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am. J. Ophthalmol. 131:19-24, 2001.
29. Christiansen, G.A., Nau, C.B., McLaren, J.W., et al. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology 111:1658-1662, 2004.
30. 2α. Arch. Ophthalmol. 105:1112-1116, 1987.
31. Fechtner, R.D., Khouri, A.S., Zimmerman, T.J., et al. Anterior uveitis associated with latanoprost. Am. J. Ophthalmol. 126:37-41, 1998.
32. Callanan, D., Fellman, R.L., and Savage, J.A. Latanoprost-associated cystoid macular edema. Am. J. Ophthalmol. 126:134-135, 1998.
33. Miyake, K., Ota, I., Maekubo, K., et al. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch. Ophthalmol. 117:34-40, 1999.